LicostinelAlternative Names: ACEA 1021
Latest Information Update: 23 Dec 2002
At a glance
- Originator Purdue Pharma
- Class Quinoxalines; Small molecules
- Mechanism of Action Glutamate receptor antagonists; Glycine NMDA-associated antagonists; NMDA receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Craniocerebral trauma; Neuroprotection; Pain; Stroke